The study revealed that patients with hemophilia have elevated baseline levels of platelet activation, indicated by increased platelet P-selectin expression and higher plasma concentrations of the soluble platelet activation markers PF4, CXCL7, and RANTES when compared to healthy controls. Here, CCL5 is linked to hemophilia.